Peris-Subiza J, Obach V, Guisado-Alonso D, Velasco Juanes F, et al. Effectiveness and tolerability of galcanezumab for migraine prevention in patients >/=65 years: A real-life multicenter study. Headache 2025 Oct 14. doi: 10.1111/head.15064.
PMID: 41085017